Enanta Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $237k | 19k | 12.67 |
| 2025-12-31 | $228k | 14k | 15.82 |
| 2025-09-30 | $122k | 10k | 12.02 |
| 2023-09-30 | $131k | 12k | 11.22 |
| 2023-03-31 | $6.6M | 163k | 40.44 |
| 2022-12-31 | $8.1M | 174k | 46.52 |
| 2022-03-31 | $14M | 193k | 71.18 |
| 2021-12-31 | $21M | 274k | 74.78 |
| 2021-09-30 | $15M | 262k | 56.81 |
| 2021-06-30 | $11M | 253k | 44.01 |
| 2021-03-31 | $43M | 864k | 49.32 |
| 2020-12-31 | $41M | 961k | 42.10 |
| 2020-09-30 | $45M | 974k | 45.78 |
| 2020-06-30 | $64M | 1.3M | 50.21 |
| 2020-03-31 | $70M | 1.4M | 51.43 |
| 2019-12-31 | $86M | 1.4M | 61.78 |
| 2019-09-30 | $93M | 1.6M | 60.08 |
| 2019-06-30 | $129M | 1.5M | 84.38 |
| 2019-03-31 | $131M | 1.4M | 95.52 |
| 2018-12-31 | $76M | 1.1M | 70.83 |
| 2018-09-30 | $91M | 1.1M | 85.46 |
| 2018-06-30 | $99M | 856k | 115.90 |
| 2018-03-31 | $26M | 318k | 80.91 |
| 2017-12-31 | $22M | 372k | 58.68 |